PASSAGE BIO, INC. (PASG) Operating cash flow 2019–2025
PASSAGE BIO, INC. (PASG) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$31.5MFY2025 · since FY2019: -$39.9M → -$31.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.5M | +34.3% |
| FY2024 | -$48.0M | +38.7% |
| FY2023 | -$78.3M | +33.8% |
| FY2022 | -$118.2M | +6.8% |
| FY2021 | -$126.9M | -57.6% |
| FY2020 | -$80.5M | -101.8% |
| FY2019 | -$39.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PASG financial trends
PASG RevenuePASG Net incomePASG Net marginPASG Gross profitPASG Gross marginPASG Operating incomePASG Operating marginPASG Free cash flowPASG Capital expendituresPASG Return on equityPASG Stock buybacksPASG Dividends paidPASG Total assetsPASG Total liabilitiesPASG Shareholders’ equityPASG overview →